Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
Food and Drug Administration Approval Letter for Alemtuzumab
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
Ustekinumab.
Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in relapsing-Remitting Multiple Sclerosis
Dynamic regulatory network controlling TH17 cell differentiation.
Analysis: Healthy babies born after accelerated elimination of teriflunomide
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Teva to present positive data for glatiramer acetate 40 mg/1 ml given three times weekly for relapsing-remitting MS
BTG Commences Phase IIa Study of Multiple Sclerosis
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.

Pages